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Half tabletsAbstract Background: Tablet splitting is often used in pharmacy practice to adjust the adminis-
tered doses. It is also used as a method of reducing medication costs.
Objective: To investigate the accuracy of tablet splitting by comparing hand splitting vs. a tablet
cutter for a low dose drug tablet.
Methods: Salbutamol tablets (4 mg) were chosen as low dose tablets. A randomly selected equal
number of tablets were split by hand and a tablet cutter, and the remaining tablets were kept whole.
Weight variation and drug content were analysed for salbutamol in 0.1 N HCl using a validated
spectrophotometric method. The percentages by which each whole tablet’s or half-tablet’s drug con-
tent and weight difference from sample mean values were compared with USP speciﬁcation ranges
for drug content. The %RSD was also calculated in order to determine whether the drugs met USP
speciﬁcation for %RSD. The tablets and half tablets were scanned using electron microscopy to
show any visual differences arising from splitting.
Results: 27.5% of samples differed from sample mean values by a percentage that fell outside of
USP speciﬁcation for weight, of which 15% from the tablet cutter and 25% from those split by
hand fell outside the speciﬁcations. All whole tablets and half tablets met the USP speciﬁcations
for drug content but the variation of content between the two halves reached 21.3% of total content
in case of hand splitting, and 7.13% only for the tablet cutter. The %RSDs for drug content and
weight met the USP speciﬁcation for whole salbutamol tablets and the half tablets which were split
Accuracy of tablet splitting: Comparison study between hand splitting and tablet cutter 455by tablet cutter. The halves which were split by hand fell outside the speciﬁcation for %RSD (drug
content = 6.43%, weight = 8.33%). The differences were visually clear in the electron microscope
scans.
Conclusion: Drug content variation in half-tablets appeared to be attributable to weight varia-
tion occurring during the splitting process. This could have serious clinical consequences for med-
ications with a narrow therapeutic-toxic range. On the basis of our results, we recommend to avoid
tablet splitting whenever possible or the use of an accurate tablet splitting device when splitting can-
not be avoided.
ª 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Although it is most common to use the whole tablets in ther-
apy, they can be divided into halves (Duman et al., 2000; Ver-
rue et al., 2011). Dividing a solid dosage form offers the
advantages of ease of administration to the elderly, children
or patients who have difﬁculty in swallowing (Duman et al.,
2000), to achieve doses less than the smallest available manu-
factured strength and it is also being advocated as a method
of reducing prescription drug costs .The cost of some medica-
tion regimens can be decreased by as much as 50% (McDevitt
et al., 1998).
Uneven breaking of a tablet may result in signiﬁcant ﬂuctu-
ations in the administered dose. This may be clinically signiﬁ-
cant for drugs with a narrow therapeutic range, such as
warfarin or digoxin. For many drugs, however, especially
those with long half-lives and/or a wide therapeutic range,
dose ﬂuctuations are unlikely to be clinically signiﬁcant.
Unless breaking tablets where dosage is not a major issue
such as vitamins or analgesics, splitting tablets is not a good
idea. If breaking tablets is necessary, a special tablet splitting
gadget can be used. Splitting of tablets should not be pre-
scribed for serious medical conditions, extended-release or en-
teric-coated tablets and tablets without a score line.
There are many different ways to split tablets in half. One
way is to purchase a tablet splitter from your local pharmacy
(see Fig. 1). These tablet splitters are safe and easy to use.
All you need to do is to place the tablet in the proper place
and then when the splitter is closed, a steel blade cuts the tablet
in halves. Some tablets are scored and have a line dividing the
dose in half and may be able to be snapped in half using your
ﬁngers. Other alternatives used are splitting by hands (for
scored tablets) or with scissors (for unscored tablets), or with
a kitchen knife (Verrue et al., 2011).
Tablets with score line allow the administration of a por-
tion of the tablet, which can then be considered as the unit dos-Figure 1 Different desage of the drug. However, actual dosages of hand-split tablets
may deviate by more than 20% (McDevitt et al., 1998) and it
may pose a serious risk for tablet uniformity and differ in the
content of the two halves resulting in high or low blood levels
which may affect the cure of the disease (Duman et al., 2000;
Teng et al., 2002) especially if the dose is critical in disease
treatment.
Few reports compared the bioavailability and dissolution
of whole vs. half of the tablets and little effort has focus on
the scoring effect on the uniform tablet divisibility (Duman
et al., 2000). Properly scored tablets are necessary to divide
the tablets into two equal halves (Duman et al., 2000). Besides
the manufacturers’ decision on tablet scoring, human factors
(physical and psychological) affect the ﬁnal performance of
the scored tablet (Duman et al., 2000). Nonetheless, a litera-
ture review concluded that the available literature was limited
to adequately address the safety of this practice (McDevitt
et al., 1998).
Salbutamol tablet was used as a model in this study. Salbu-
tamol or albuterol is a short-acting b2-adrenergic receptor
agonist used for the relief of bronchospasm in conditions such
as asthma (one of the most common chronic diseases in Saudi
Arabia), and chronic obstructive pulmonary disease.
The aim of the current study is to investigate the drug con-
tent and weight of the split half tablet by hand vs. use of tablet
cutter comparing with whole tablet for Salbutamol using the
drug assay analysis.
2. Materials and methods
2.1. Materials
Salbutamol 2 mg and 4 mg tablets were studied (Table 1). This
drug was chosen because it is widely used in Saudi Arabia for
the treatment of asthma and its low dose (4 mg) as well as the
presence of whole tablet (2 mg) which will be as standard forign of tablet splitter.
Table 1 Description of salbutamol tablets studied.
Drug Tablet description Scored Observationsa
Salbutamol 4 mg Pink, non-coated, circular tablet Yes Minimal powdering with tablet splitter, fractured at score
Salbutamol 2 mg Orange, non-coated, circular tablet Yes Minimal powdering with tablet splitter, fractured at score
a Observation of tablet characteristics were made during the tablet splitting process.
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pharmaceutical grade.
2.2. Methods
2.2.1. Spectrophotometric scanning of salbutamol sulphate
47.8 mg of salbutamol sulphate (equal to 39.83 mg of salbuta-
mol) was dissolved in 100 ml of 0.1 N HCl. Then the samples
of resulting solution were scanned for UV absorption (in range
between 200 and 400 nm) via a UV system using a double-
beam spectrophotometer Shimadzu (UV-160A) and matched
1-cm optical quartz cell to determine maximum absorption
wavelength.
2.2.2. Calibration curve of salbutamol sulphate in 0.1 N HCl at
(225 and 276.5 nm)
A standard curve was created for salbutamol sulphate, using
pure drug powder diluted to 3 known concentrations (range
between 0.0096 and 0.0478 mg/ml). These standard curves
were established to verify accurate analysis of the drug.
2.2.3. Scanning electron microscope
A scanning electron microscope (SEM) is a type of electron
microscope that images a sample by scanning it with a high-en-
ergy beam of electrons in a raster scan pattern. The electrons
interact with the atoms that make up the sample producing sig-
nals that contain information about the sample’s surface
topography, composition, and other properties such as electri-
cal conductivity. SEM studies were done by research centre of
the dentistry college, KSU.
2.2.4. Weight variation
A total of 20 whole tablets were randomly selected from salbu-
tamol 4 mg and another 20 whole tablets from salbutamol
2 mg. Ten of the 20 randomly selected tablets of salbutamol
4 mg were split in halves using a Locking Tablet Cutter
(Apothecary Products, Inc.) and the other 10 tablets were split
in half by hand. All 20 whole tablets from 2 mg and 40 half
tablets from 4 mg were weighted using a Mettler Toledo
Aj150 (Mettler Toledo, Inc., Columbus, Ohio) analytical bal-
ance. The individual weight was compared with an average
weight. Not more than two of the individual weights deviated
from the ofﬁcial standard (limit ±7.5%). Assay parameters
for each drug were taken directly from USP monographs.
2.2.5. Content uniformity
First the 10 whole tablets of 2 mg and 20 half-tablets selected
from 40 halves were dissolved individually using a combina-
tion of shaking and sonication techniques in 25 ml of 0.1 N
HCl. Then the samples were mixed well before ﬁltrationthrough a membrane ﬁlter. All tablets were assayed in accor-
dance with developed and validated spectrophotometric meth-
od for determining content uniformity for whole tablets. Assay
parameters for each drug were taken directly from USP mono-
graphs. The samples of each solution were assayed for drug
concentration via UV system using a spectro UV-UIS Dual
beam (uvs-2800, labomed, Inc.). The drug content was quanti-
ﬁed by calculating the concentrations from the absorbance
readings obtained through UV analysis of whole and half-tab-
let samples.
To assess the amount and acceptability of variations in
drug content and weight, several measures were calculated.
The measured drug content expressed as a percent of label
claim was calculated for both whole and half-tablets. Individ-
ual values for whole tablets should be in the range of 85–115%
for the drugs studied (proxy USP speciﬁcation for drug con-
tent). Relative standard deviation expressed as a percentage
(%RSD), was calculated for whole tablets (drug content and
weight) and for half-tablets (drug content and weight). The
%RSD is widely used to assess the repeatability and precision
of the assays used to analyse drug content. Individual medica-
tion lots for whole tablets are targeted to have a %RSD less
than 6% (proxy USP speciﬁcation for %RSD).3. Results and discussion
3.1. Spectrophotometric scanning of salbutamol sulphate
The spectrophotometric scanning of salbutamol sulphate in
0.1 N HCl showed that there are two maximum absorption
wavelengths at 225 and 276.5 nm (Fig. 2).3.2. Calibration curve of salbutamol sulphate in 0.1 N HCl at
(225 and 276.5 nm)
A linear relationship between the absorbance and the concen-
tration of salbutamol sulphate in 0.1 N HCl at (225 and
276.5 nm), in the concentration range of 0.0096–0.0478 mg/
ml was observed. The regression equation is Y= 20.688
X+ 0.0096 and the correlation coefﬁcients (r) of the linear
regression of the calibration curves is 0.9999.3.3. Scanning electron microscope
The image shows that after breaking, the tablet produces some
of the terrain to either increase or decrease in the fracture. It
has been noted that these features exist in both cases (hand
and splitter) and more clearly when using the hand. The fol-
lowings are some of the SEM photographs showing this.
Table 2 Weight variation test for whole tablets.
No. Weight (g) Diﬀerence from the mean %RSD
1 0.1175 0.0029 2.39
2 0.1170 0.0010 0.85
3 0.1214 0.0010 0.85
4 0.1218 0.0014 1.18
5 0.1184 0.0020 1.64
6 0.1179 0.0025 2.06
7 0.1190 0.0014 1.14
8 0.1195 0.0009 0.73
9 0.1215 0.0011 0.93
10 0.1164 0.0040 3.30
11 0.1192 0.0012 0.98
12 0.1263 0.0059 4.92
13 0.1214 0.0010 0.85
14 0.1204 0.0000 0.02
15 0.1155 0.0049 4.05
16 0.1241 0.0037 3.09
17 0.1201 0.0003 0.23
18 0.1217 0.0013 1.10
19 0.1237 0.0033 2.76
20 0.1247 0.0043 3.59
Mean = 0.1204 g.
SD = 0.0029.
%RSD= 2.41.
Salbutamol tablet split by hand:
Salbutamol tablet split by splitter:
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For all whole tablets studied, measured tablet weight expressed
as a percent of target weight (see Table 2) was found to fall
within the proxy USP speciﬁcation percentage range. The
weight variation increased signiﬁcantly after splitting com-
pared to the intact tablets (see Tables 3 and 4). Measured
weight expressed as a percent of target weight for half-tablets
fell outside the proxy USP speciﬁcation for weight for at least
3 half-tablets when cutter was used (15%), while the number
increased when tablet was split by hand to 8 half-tablets
(25%).
3.4.1. Statistical analysis
3.4.1.1. t-Test. The mean of weight variation test for half tab-
lets split by hand is 0.0606, while the mean of weight variation
test for half tablets split by splitter is 0.0608. The t-value calcu-Figure 2 Absorption spectrum of salated is 1.8964 with a degree of freedom of 38; meanwhile, the
t-value tabulated is 2.02 at 95% conﬁdence interval. The t-va-
lue calculated is less than the t-value tabulated so there is no
different between the two means.
3.4.1.2. F-test. The SD of tablets split by hand is 0.005 and the
SD of tablets split by splitter is 0.0031. Accordingly, the F-va-
lue calculated is 2.604 with a degree of freedom of 19; mean-
while, the F-value tabulated is 2.17 at 95% conﬁdence
interval. Accordingly, the F-value calculated is more than the
tabulated F-value and that gives evidence of unequal popula-
tion variances.
3.5. Drug content
The measured drug content was expressed as a percent of tar-
get drug content for all whole tablets and half tablets met the
proxy USP speciﬁcation for %RSD (see Tables 5–7). While the
percentage of content variation between the two halves can
reach 21.3% of total content in case of hand splitting; using
the Locking Tablet Cutter gave a maximum variation of only
7.13%.lbutamol sulphate in 0.1 N HCl.
Table 3 Weight variation test for half tablet split by hand.
No. Weight (g) Diﬀerence from the Mean %RSD
1 0.0710 0.0104 17.17
2 0.0550 0.0056 9.23
3 0.0640 0.0034 5.62
4 0.0588 0.0018 2.96
5 0.0547 0.0059 9.73
6 0.0631 0.0025 4.13
7 0.0623 0.0017 2.81
8 0.0600 0.0006 0.98
9 0.0610 0.0004 0.67
10 0.0599 0.0007 1.15
11 0.0571 0.0035 5.77
12 0.0640 0.0034 5.62
13 0.0536 0.0070 11.54
14 0.0606 0.0000 0.01
15 0.0550 0.0056 9.23
16 0.0680 0.0074 12.22
17 0.0526 0.0080 13.19
18 0.0672 0.0066 10.90
19 0.0593 0.0013 2.14
20 0.0647 0.0041 6.77
Mean = 0.0606.
SD = 0.0050.
%RSD= 8.33.
Table 4 Weight variation test for half tablet split by splitter.
No. Weight (g) Diﬀerence from the Mean %RSD
1 0.0629 0.0021 3.54
2 0.0589 0.0019 3.05
3 0.0598 0.0010 1.56
4 0.0604 0.0004 0.58
5 0.0625 0.0017 2.88
6 0.0588 0.0020 3.21
7 0.0614 0.0006 1.07
8 0.0671 0.0064 10.45
9 0.0585 0.0023 3.70
10 0.0625 0.0017 2.88
11 0.0574 0.0034 5.51
12 0.0593 0.0015 2.39
13 0.0633 0.0025 4.20
14 0.0590 0.0018 2.88
15 0.0630 0.0023 3.70
16 0.0601 0.0007 1.07
17 0.0550 0.0058 9.47
18 0.0649 0.0041 6.83
19 0.0557 0.0051 8.31
20 0.0645 0.0038 6.17
Mean = 0.0608.
SD = 0.0031.
%RSD= 5.11.
Table 5 Salbutamol 2 mg whole tablets drug content.
No. Weight Content%
1 0.1175 102.01
2 0.1170 100.10
3 0.1214 103.36
4 0.1218 104.00
5 0.1184 100.89
6 0.1179 101.06
7 0.1190 103.10
8 0.1195 102.11
9 0.1215 104.94
10 0.1164 100.65
Mean 0.1190 102.22
SD 0.0020 1.59
%RSD 1.65 1.56
Table 6 Drug content for half tablets split by hand.
No. Weight Content (% of label claim)
Half tablet Whole tablet Range
1 0.0710 111.20 100.54 21.31
2 0.0550 89.89
3 0.0640 102.37 99.29 6.17
4 0.0588 96.21
5 0.0547 89.50 95.27 11.55
6 0.0631 101.05
7 0.0623 100.70 99.05 3.29
8 0.0600 97.41
9 0.0610 100.43 98.05 4.75
10 0.0599 95.67
Mean 0.0610 98.44
SD 0.0047 6.33
%RSD 7.69 6.43
Table 7 Drug content for half tablets split by tablet cutter.
No. Weight Content (% of label claim)
Half tablet Whole tablet Range
1 0.0629 94.55 95.85 2.60
2 0.0589 97.15
3 0.0598 96.90 98.25 2.70
4 0.0604 99.59
5 0.0625 99.30 98.06 2.50
6 0.0588 96.81
7 0.0614 97.02 100.58 7.13
8 0.0671 104.15
9 0.0585 94.36 97.26 5.80
10 0.0625 100.16
Mean 0.0613 98.00
SD 0.0026 2.91
%RSD 4.28 2.97
458 W.A. Habib et al.3.5.1. t-Test
The mean of drug content for half tablets split by hand is
98.44, while the mean of drug content for half tablets split
by cutter is 98.00. The t-value calculated is 0.201485 with a de-
gree of freedom of 18. The t-value tabulated is 2.1 at 95% con-
ﬁdence interval. The t-value calculated is less than the t-value
tabulated so there is no different between the two means.3.5.2. F-test
The SD for the tablets split by hand is 6.33, and the SD for
tablets split by splitter is 2.91. Accordingly, the calculated F-
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tabulated F-value is 3.18 at 95% conﬁdence interval. Accord-
ingly, the F-value calculated is more than the tabulated F-value
and that gives evidence of unequal population variances.
4. Conclusion
Tablet splitting may not have adverse clinical consequences
and can reduce costs for both patients and institutions (Verrue
et al., 2011), but using a whole tablet is the safest way to ensure
accurate dosing. However, not all formulations are suitable for
splitting, and even when they are, it may lead to dose devia-
tions. This could have serious clinical consequences for medi-
cations with a narrow therapeutic-toxic range. On the basis
of our results, which demonstrated that using accurate tablet
cutter is superior to hand splitting, we recommend the use of
an accurate splitting device when splitting cannot be avoided
(i.e. for example when the prescribed dose is not commercially
available, or when there is no alternative formulation, such as
a liquid). Nursing home staff performing the splitting should
also be educated in splitting as accurately as possible, and
should be aware of the possible clinical consequences of dose
deviations. As for policy implications, we concur with previous
scientiﬁc recommendations (Teng et al., 2002) that manufac-turers make it possible to avoid splitting, by introducing a
wider range of tablet doses or liquid formulations.Acknowledgement
The authors would like to thank Al-Kayyali chair of pharma-
ceutical industry for hosting the work, and supplying the mate-
rials and equipment.
Reference
Duman, E., Yuksel, N., Olin, B., Sakr, A., 2000. Effect of scoring
design on the uniformity of extended release matrix tablet halves.
Pharm. Ind. 62, 547–550.
McDevitt, J.T., Gurst, A.H., Chen, Y., 1998. Accuracy of tablet
splitting. Pharmacotherapy 18, 193–197.
Teng, J., Song, C., Williams, R., Polli, J., 2002. Lack of medication
dose uniformity in commonly split tablets. J. Am. Pharm. Assoc.
42, 195–199.
Verrue, C., Mehuys, E., Boussery, K., Remon, J., Petrovic, M., 2011.
Tablet-splitting: a common yet not so innocent practice. J. Adv.
Nurs. 67, 26–32.
